한글목차

풍진 백신의 동향과 전망

세계 풍진 백신 시장 규모는 2024-2030년 동안 4.1%의 CAGR로 성장하여 2030년까지 약 2억 4,500만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 동인은 혼합 백신에 대한 수요 증가와 신흥국의 풍진 예방접종 프로그램 채택률 증가로 인한 것입니다. 세계 풍진 백신 시장의 잠재력은 병원, NGO 및 소아과 클리닉 시장에서의 기회로 인해 유망합니다.

풍진 백신 시장 인사이트

Lucintel의 예측에 따르면, 홍역 풍진 백신은 홍역과 풍진을 포함한 두 가지 전염성이 강한 질병을 예방하기 위해 사용될 것이며, 예측 기간 동안 가장 높은 성장을 보일 것으로 예상됩니다.

북미는 백신 접종률이 높고, 주요 제조업체들이 이 지역에 존재하기 때문에 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

시장 규모 및 추정치: 풍진 백신 시장 규모를 금액(100만 달러)으로 추정

동향 및 예측 분석 : 각 부문별, 지역별 시장 동향(2018-2023년) 및 예측(2024-2030년)

세분화 분석 : 유형별, 최종 용도별, 지역별 풍진 백신 시장 규모를 금액(백만 달러)으로 추정

지역별 분석 : 북미, 유럽, 아시아태평양 및 기타 지역의 풍진 백신 시장 분석

전략적 분석 : 풍진 백신 시장의 유형별, 최종 용도별, 지역별 성장 기회 분석

전략 분석 : 풍진 백신 시장의 M&A, 신제품 개발, 경쟁 구도 등

Porter's Five Forces 모델을 기반으로 한 산업 경쟁 강도 분석

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 풍진 백신 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석 : 2018-2030년

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 풍진 백신 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 풍진 백신 시장 : 유형별
  • 단가 제형
  • 홍역/풍진 백신
  • 홍역/볼거리/풍진 백신
  • 홍역/볼거리/풍진/수두 백신
• 세계의 풍진 백신 시장 : 최종 용도별
  • 병원
  • NGO
  • 소아과 클리닉
  • 기타

제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)

• 세계의 풍진 백신 시장 : 지역별
• 북미의 풍진 백신 시장
• 유럽의 풍진 백신 시장
• 아시아태평양의 풍진 백신 시장
• 기타 지역의 풍진 백신 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 풍진 백신 시장 성장 기회
  • 최종 용도별 세계의 풍진 백신 시장 성장 기회
  • 지역별 세계의 풍진 백신 시장 성장 기회
• 세계 풍진 백신 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 풍진 백신 시장 생산능력 확대
  • 세계의 풍진 백신 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• Johnson & Johnson
• Sanofi Pasteur
• Bavarian Nordic
• MedImmune
• China National Biotec
• GlaxoSmithKline
• Pfizer

영문목차

Rubella Vaccine Trends and Forecast

The future of the global rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets. The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

A more than 150-page report is developed to help in your business decisions.

Rubella Vaccine by Segment

The study includes a forecast for the global rubella vaccine by type, end use, and region.

Rubella Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Monovalent Formulation
• Measles-Rubella Vaccine
• Measles, Mumps, Rubella Vaccine
• Measles Mumps Rubella Varicella Vaccine

Rubella Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• NGO'S
• Pediatric Clinics
• Others

Rubella Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Rubella Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rubella vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rubella vaccine companies profiled in this report include-

• Johnson & Johnson
• Sanofi Pasteur
• Bavarian Nordic
• Medimmune
• China National Biotec
• Glaxosmithkline
• Pfizer

Rubella Vaccine Market Insights

Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Features of the Global Rubella Vaccine Market

Market Size Estimates: Rubella vaccine market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rubella vaccine market size by type, end use, and region in terms of value ($M).

Regional Analysis: Rubella vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the rubella vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rubella vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rubella vaccine market size?

Answer: The global rubella vaccine market is expected to reach an estimated $245.0 million by 2030.

Q.2 What is the growth forecast for rubella vaccine market?

Answer: The global rubella vaccine market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rubella vaccine market?

Answer: The major drivers for this market are growing demand for combination vaccines and rising adoption of rubella vaccination programs in developing countries.

Q4. What are the major segments for rubella vaccine market?

Answer: The future of the rubella vaccine market looks promising with opportunities in the hospital, NGO, and pediatric clinic markets.

Q5. Who are the key rubella vaccine market companies?

Answer: Some of the key rubella vaccine companies are as follows:

• Johnson & Johnson
• Sanofi Pasteur
• Bavarian Nordic
• Medimmune
• China National Biotec
• Glaxosmithkline
• Pfizer

Q6. Which rubella vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that measles-rubella vaccine is expected to witness highest growth over the forecast period due to it growing usage to protect against two highly contagious diseases including measles and rubella.

Q7. In rubella vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to high vaccination coverage rates and presence of key manufacturer in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the rubella vaccine market by type (monovalent formulation, measles-rubella vaccine, measles, mumps, rubella vaccine, and measles mumps rubella varicella vaccine), end use (hospitals, NGO's, pediatric clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rubella Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Rubella Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Rubella Vaccine Market by Type
  • 3.3.1: Monovalent Formulation
  • 3.3.2: Measles-Rubella Vaccine
  • 3.3.3: Measles, Mumps, Rubella Vaccine
  • 3.3.4: Measles Mumps Rubella Varicella Vaccine
• 3.4: Global Rubella Vaccine Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: NGO's
  • 3.4.3: Pediatric Clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Rubella Vaccine Market by Region
• 4.2: North American Rubella Vaccine Market
  • 4.2.2: North American Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
• 4.3: European Rubella Vaccine Market
  • 4.3.1: European Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
  • 4.3.2: European Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
• 4.4: APAC Rubella Vaccine Market
  • 4.4.1: APAC Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
  • 4.4.2: APAC Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others
• 4.5: ROW Rubella Vaccine Market
  • 4.5.1: ROW Rubella Vaccine Market by Type: Monovalent Formulation, Measles-Rubella Vaccine, Measles, Mumps, Rubella Vaccine, and Measles Mumps Rubella Varicella Vaccine
  • 4.5.2: ROW Rubella Vaccine Market by End Use: Hospitals, NGO's, Pediatric Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Rubella Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Rubella Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Rubella Vaccine Market by Region
• 6.2: Emerging Trends in the Global Rubella Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Rubella Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rubella Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Johnson & Johnson
• 7.2: Sanofi Pasteur
• 7.3: Bavarian Nordic
• 7.4: MedImmune
• 7.5: China National Biotec
• 7.6: GlaxoSmithKline
• 7.7: Pfizer